IMCAS bring together the latest evidence-based techniques from prominent speakers and the newest developments from the major industry players.
The primary objective is to build a bridge between plastic surgery and cosmetic dermatology, reinforcing knowledge in each field in the junction of those two fields, covering as well aesthetic surgery, non-invasive aesthetic treatments, clinical dermatology, regenerative medicine and more.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze